AnRes Clinical

Executive Summary

AnRes Clinical is a Copenhagen-based consultancy specializing in sponsor-side clinical trial oversight, CRO selection, protocol development, and regulatory strategy for biotech companies conducting Phase 1–3 studies globally. Founded in 2015, the firm fills a critical niche by providing expert guidance to emerging biotechs that lack in-house clinical operations teams. With the increasing complexity of global trials and a growing trend toward outsourcing non-core functions, AnRes Clinical is well-positioned to capture demand from small and mid-sized biotechs seeking to accelerate development timelines and reduce operational risks. The company’s growth prospects are tied to the broader expansion of the clinical trial services market, which is projected to grow at a CAGR of 8-10% through 2030. AnRes Clinical can differentiate itself through deep regulatory knowledge and flexible engagement models. However, as a private consultancy, it faces competition from larger CROs and consultancy firms. Key near-term drivers include expanding its client base into the US and European markets, forging strategic alliances with technology providers, and potentially developing proprietary digital tools to enhance trial oversight. Overall, AnRes Clinical represents a steady but niche opportunity in the clinical development ecosystem.

Upcoming Catalysts (preview)

• Q3 2026Expansion into US market via new client partnerships70% success
• Q4 2025Strategic partnership with a top-10 CRO50% success
• Q2 2026Launch of digital trial oversight platform60% success